Davita Stock Price, News & Analysis (NYSE:DVA)

Davita trades on the New York Stock Exchange (NYSE) under the ticker symbol "DVA."

Davita Inc (NYSE:DVA) issued its quarterly earnings results on Thursday, August, 1st. The company reported $1.22 EPS for the quarter, beating analysts' consensus estimates of $1.10 by $0.12. The company had revenue of $2.84 billion for the quarter, compared to analyst estimates of $2.86 billion. Davita had a return on equity of 14.67% and a net margin of 1.21%. The company's quarterly revenue was down 1.5% compared to the same quarter last year. During the same period in the previous year, the company posted $1.05 earnings per share. View Davita's Earnings History.

Davita is scheduled to release their next quarterly earnings announcement on Wednesday, November 6th 2019. View Earnings Estimates for Davita.

8 equities research analysts have issued 12-month target prices for Davita's shares. Their predictions range from $60.00 to $70.00. On average, they anticipate Davita's stock price to reach $65.35 in the next year. This suggests a possible upside of 15.2% from the stock's current price. View Analyst Price Targets for Davita.

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Davita in the last year. There are currently 6 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Davita.

Press coverage about DVA stock has been trending neutral recently, according to InfoTrie. The research firm ranks the sentiment of news coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Davita earned a media sentiment score of 0.4 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the company's share price in the next several days. View News Stories for Davita.

Davita saw a drop in short interest in September. As of September 30th, there was short interest totalling 10,930,000 shares, a drop of 16.8% from the August 30th total of 13,130,000 shares. Based on an average daily volume of 3,100,000 shares, the short-interest ratio is presently 3.5 days. Currently, 7.1% of the shares of the stock are short sold. View Davita's Current Options Chain.

Some companies that are related to Davita include Fresenius Medical Care AG & Co. (FMS), Livongo Health (LVGO), Tivity Health (TVTY), HemaCare (HEMA), Catasys (CATS), American Renal Associates (ARA), Emmaus Life Sciences (EMMA), Caladrius Biosciences (CLBS), Pacific Health Care Organization (PFHO), BioRestorative Therapies (BRTX) and American Caresource (GNOW).

Based on aggregate information from My MarketBeat watchlists, some companies that other Davita investors own include CA (CA), BlackRock (BLK), Endologix (ELGX), Chipotle Mexican Grill (CMG), Aegean Marine Petroleum Network (ANW), AutoZone (AZO), Micron Technology (MU), Designer Brands (DBI), Precision Drilling (PD) and United Rentals (URI).

Davita's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Crossmark Global Holdings Inc. (0.02%), State of Alaska Department of Revenue (0.01%), Rothschild Investment Corp IL (0.01%), Pacer Advisors Inc. (0.01%), Stonebridge Capital Management Inc. (0.01%) and Lau Associates LLC (0.01%). Company insiders that own Davita stock include Charles Berg, James K Hilger, Javier Rodriguez, Kent J Thiry, Leanne M Zumwalt, Pamela M Arway and William L Roper. View Institutional Ownership Trends for Davita.

DVA stock was sold by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue, Lau Associates LLC, Stonebridge Capital Management Inc., Crossmark Global Holdings Inc. and Pacer Advisors Inc.. View Insider Buying and Selling for Davita.

DVA stock was purchased by a variety of institutional investors in the last quarter, including Rothschild Investment Corp IL, NuWave Investment Management LLC and North Star Investment Management Corp.. View Insider Buying and Selling for Davita.

Shares of DVA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of DVA stock can currently be purchased for approximately $56.72.

Davita has a market capitalization of $9.09 billion and generates $11.40 billion in revenue each year. The company earns $159.39 million in net income (profit) each year or $3.57 on an earnings per share basis. Davita employs 77,700 workers across the globe.View Additional Information About Davita.

The official website for Davita is http://www.davita.com/.

Davita's mailing address is 2000 16TH STREET, DENVER CO, 80202. The company can be reached via phone at 720-631-2100 or via email at [email protected]